Stage 0is Urethral Cancer AJCC v8
1 clinical trials · Condition
◉ Watch Stage 0is Urethral Cancer AJCC v8
| Record | Firm | Date |
|---|---|---|
| Erlotinib Hydrochloride in Treating Participants With Muscle Invasive or Recurrent Urothelial Cancer (NCT00749892) | M.D. Anderson Cancer Center | 2008-06-10 |
Track Stage 0is Urethral Cancer AJCC v8 automatically
Every clearance here is in the API, with alerts when new ones post.